Change Agents Corporation, together with its subsidiaries, develops innovative artificial intelligence platforms in the United States and China. It operates through Consumer Health Technology and Artificial Intelligence Content Technology Segment. The company offers automated video generation, enterprise documentation, and workflow automation solutions, as well as cellular therapy and generative AI publishing and software. It also distributes the KetoAir device, which is a breathalyzer system that detects acetone levels in exhaled breath; and the AI Nutritionist software program that helps…
| Price | $2.06 |
|---|---|
| Market cap | $1.5M |
| Sector | Technology |
| Industry | Software - Application |
| Exchange | NASDAQ |
| 52-week range | 1.795-55.4 |
| Beta | -0.04 |
Explore CHGA's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.